A detailed history of Aimz Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 58,095 shares of AZN stock, worth $3.73 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
58,095
Previous 58,709 1.05%
Holding current value
$3.73 Million
Previous $4.58 Million 1.14%
% of portfolio
1.56%
Previous 1.66%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $47,075 - $53,798
-614 Reduced 1.05%
58,095 $4.53 Million
Q2 2024

Aug 07, 2024

SELL
$66.81 - $80.83 $33,739 - $40,819
-505 Reduced 0.85%
58,709 $4.58 Million
Q1 2024

May 10, 2024

SELL
$61.03 - $69.57 $51,265 - $58,438
-840 Reduced 1.4%
59,214 $4.01 Million
Q4 2023

Jan 26, 2024

SELL
$61.89 - $69.28 $65,665 - $73,506
-1,061 Reduced 1.74%
60,054 $4.04 Million
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $27,496 - $30,400
-424 Reduced 0.69%
61,115 $4.14 Million
Q2 2023

Aug 08, 2023

SELL
$69.91 - $75.81 $4,753 - $5,155
-68 Reduced 0.11%
61,539 $4.4 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $64,539 - $73,175
-1,022 Reduced 1.63%
61,607 $4.28 Million
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $1,192 - $1,549
-22 Reduced 0.04%
62,629 $4.25 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $13,679 - $35,023
-258 Reduced 0.41%
62,651 $3.44 Million
Q2 2022

Aug 02, 2022

SELL
$59.26 - $71.14 $6,637 - $7,967
-112 Reduced 0.18%
62,909 $4.16 Million
Q1 2022

May 06, 2022

SELL
$55.72 - $67.12 $126,707 - $152,630
-2,274 Reduced 3.48%
63,021 $4.18 Million
Q4 2021

Feb 09, 2022

BUY
$54.02 - $63.83 $80,327 - $94,915
1,487 Added 2.33%
65,295 $3.8 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $3.55 Million - $3.88 Million
63,808 New
63,808 $3.83 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Aimz Investment Advisors, LLC Portfolio

Follow Aimz Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.